Doxylamine/Pyridoxine Exeltis Healthcare 20mg/ 20mg modified-release tablets Ireland - English - HPRA (Health Products Regulatory Authority)

doxylamine/pyridoxine exeltis healthcare 20mg/ 20mg modified-release tablets

exeltis healthcare s.l. - doxylamine hydrogen succinate; pyridoxine hydrochloride - modified-release tablet - doxylamine, combinations

Doxylamine/Pyridoxine Exeltis 10 mg/10 mg gastro-resistant tablets Ireland - English - HPRA (Health Products Regulatory Authority)

doxylamine/pyridoxine exeltis 10 mg/10 mg gastro-resistant tablets

exeltis healthcare s.l. - doxylamine; pyridoxine hydrochloride - gastro-resistant tablet - 10/10 milligram(s) - doxylamine, combinations

Xonvea 10 mg/10 mg gastro-resistant tablets Ireland - English - HPRA (Health Products Regulatory Authority)

xonvea 10 mg/10 mg gastro-resistant tablets

exeltis healthcare s.l. - doxylamine hydrogen succinate; pyridoxine hydrochloride - gastro-resistant tablet - doxylamine, combinations

Doxpirexel 20 mg/ 20 mg modified-release tablets Ireland - English - HPRA (Health Products Regulatory Authority)

doxpirexel 20 mg/ 20 mg modified-release tablets

exeltis healthcare s.l. - pyridoxine hydrochloride ; doxylamine hydrogen succinate - modified-release tablet - doxylamine, combinations

Xonvea MR 20 mg/20 mg modified-release tablets Ireland - English - HPRA (Health Products Regulatory Authority)

xonvea mr 20 mg/20 mg modified-release tablets

exeltis healthcare s.l. - doxylamine hydrogen succinate; pyridoxine hydrochloride - modified-release tablet - doxylamine, combinations

Slyndy 4 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

slyndy 4 mg film-coated tablets

exeltis healthcare s.l. - drospirenone - film-coated tablet - 4 milligram(s) - drospirenone

VITAFOL- cholecalciferol, pyridoxine hydrochloride, cyanocobalamin, and folic acid strip United States - English - NLM (National Library of Medicine)

vitafol- cholecalciferol, pyridoxine hydrochloride, cyanocobalamin, and folic acid strip

exeltis usa, inc. - cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8) - vitafol® strips is contraindicated in patients with hypersensitivity to any of its components or color additives. folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (vitamin b12).

VITAFOL FE PLUS- doconexent, niacinamide, .alpha.-tocopherol acetate, dl-, cholecalciferol, beta carotene, ascorbic acid, thiami United States - English - NLM (National Library of Medicine)

vitafol fe plus- doconexent, niacinamide, .alpha.-tocopherol acetate, dl-, cholecalciferol, beta carotene, ascorbic acid, thiami

exeltis usa, inc. - doconexent (unii: zad9okh9jc) (doconexent - unii:zad9okh9jc), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), beta carotene (unii: 01yae03m7j) (beta carotene - unii:01yae03m7j), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), r - vitafol ® fe + prenatal supplement is contraindicated in patients with hypersensitivity to any of its components or color additives. folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. iron supplementation is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver. cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (vitamin b12).

VITAFOL OB CAPLET- vitamin a, ascorbic acid, vitamin d, .alpha.-tocopherol, thiamine mononitrate, riboflavin, niacin, pyridoxine United States - English - NLM (National Library of Medicine)

vitafol ob caplet- vitamin a, ascorbic acid, vitamin d, .alpha.-tocopherol, thiamine mononitrate, riboflavin, niacin, pyridoxine

exeltis usa, inc. - vitamin a (unii: 81g40h8b0t) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin d (unii: 9vu1ki44gp) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol (unii: h4n855pnz1) (.alpha.-tocopherol - unii:h4n855pnz1), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), pyridoxine hydrochloride (unii: 68y4cf58bv) - vitamin a 2700 [iu] - vitafol ® -ob is indicated to provide vitamin, mineral, supplementation prior to conception, throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother.* vitafol ® -ob is contraindicated in patients with hypersensitivity to any of its components or color additives. folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. iron therapy is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver. cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (vitamin b-12).

SELECT-OB PLUS DHA PRENATAL SUPPLEMENT PLUS DHA- .beta.-carotene, vitamin a acetate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, levomefolate calcium, cobalamin, iron, magnesium oxide, zinc oxide, and doconexant kit United States - English - NLM (National Library of Medicine)

select-ob plus dha prenatal supplement plus dha- .beta.-carotene, vitamin a acetate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, levomefolate calcium, cobalamin, iron, magnesium oxide, zinc oxide, and doconexant kit

exeltis usa, inc. - beta carotene (unii: 01yae03m7j) (beta carotene - unii:01yae03m7j), vitamin a acetate (unii: 3le3d9d6oy) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), levomefolate calcium (unii: a9r10k3f2f) (levomefolic acid - unii:8s95dh25xc), cobalamin (unii: 8406ey2oqa) (cobalamin - unii:8406ey2oqa), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), magnesium oxide (unii: 3a3u0gi71g) (magnesium cation - unii:t6v3lhy838), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - .beta.-carotene 600 [iu] - select-ob+dha ® is indicated to provide vitamin, mineral, and omega-3 fatty acid supplementation prior to conception, throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother.* select-ob+dha ® does not contain fish, fish oils, fish proteins or fish byproducts. select-ob+dha ® is contraindicated in patients with hypersensitivity to any of its components or color additives. folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. iron therapy is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver. cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (vitaminb12).